Metabolic NAFLD complications, obesity, insulin resistance and type 2 diabetes involve a chronic “low-grade inflammation”, resulting in the increase in obesity-related inflammatory molecules, such as: TNF-alpha, IL-1beta, IL-6, IL-1Ra, and C-reactive protein (CRP) [15]. Here, CRP is linked to metabolic dysfunction-associated steatotic liver disease.